Trials / Active Not Recruiting
Active Not RecruitingNCT03477513
Personalized Radiation Therapy for GBM
Personalized Treatment of Glioblastoma Via Image-Guided Predictive Modeling of Recurrence: A Single-Arm, Single Institutional Pilot Prospective Study of Dose-Escalated Radiation Therapy
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is a pilot study to estimate the efficacy of personalized dose-escalation radiation therapy in patients with glioblastoma, as measured by estimating the median of progression-free survival. Toxicity, patterns of recurrence, and overall median survival will be measured as secondary endpoints. Adverse events will be monitored.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Radation Therapy | Personalized Radiation Therapy |
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2026-06-01
- Completion
- 2026-07-30
- First posted
- 2018-03-26
- Last updated
- 2025-06-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03477513. Inclusion in this directory is not an endorsement.